Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04331353 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Allergen Reduction and Child Health Study (ARCHS)

Study acronym: ARCHS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Enrollment target: estimated 290 to confirmed 308
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
    • Eligibility criteria expanded, about 2 words
  2. Primary and study completion dates: Apr 30, 2025 to Apr 30, 2028
    • Site contact updated
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Nov 1, 2022 to Apr 30, 2025
    • Study completion date: Apr 1, 2023 to Apr 30, 2025
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date changed from estimate of Oct 10, 2020 to Nov 15, 2020v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 1, 2020 to Oct 10, 2020
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Asthma
956 trials monitored
See 34 trials at risk
The Allergen Reduction and Child Health Study (ARCHS) is a 12-month, two group randomized control trial of children with asthma and who are exposed to cockroaches. Children ages 5 - 17 living in the Greater New Orleans area will be recruited from a variety of clinic and community settings. The overall goal of the study is to improve patient-centered asthma outcomes (asthma symptom days, health care utilization, asthma control and quality of life) by targeting one key allergen - cockroach exposure in the child's home. The investigators propose a simple intervention of insecticidal bait that is low cost, simple to implement, and which is lower toxicity than other forms of pest control. The reduction in the number of cockroaches in the home is an environmental outcome that is patient-centered and is likely to add to its acceptance by families of children with asthma.
Trial Details
NCT Number NCT04331353
Lead Sponsor Tulane University
Collaborators: Patient-Centered Outcomes Research Institute
Conditions
(from sponsor)		 Asthma in Children
Related terms Asthma
Enrollment 308 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov